FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387296265> ?p ?o ?g. }

• W4387296265 abstract "Pancreatic cancer (PC) surveillance of high-risk individuals (HRI) is becoming more common worldwide, aiming at anticipating PC diagnosis at a pre-clinical stage. In 2015 the Italian Registry of Families at Risk of Pancreatic Cancer (IRFARPC) was created. We aimed to assess the prevalence and incidence of pancreatic findings, oncological outcomes, and harms seven years after the Italian Registry of Families at Risk of Pancreatic Cancer (IRFARPC) inception focusing on individuals with at least a 3-year follow-up or developing events before.HRI (subjects with family history or mutation carriers with/without family history were enrolled in 18 Centers. They underwent annual magnetic resonance with cholangiopancreatography or endoscopic ultrasound (NCT04095195).During the study period (June 2015 - September 2022), 679 individuals were enrolled. Of these, 524 (77.2%) underwent at least baseline imaging, and 156 (29.8%) with at least a 3-year follow-up or pancreatic malignancy/pre-malignancy-related events, and represented the study population. Median age was 51 (IQR 16). Familial PC cases (FPC) accounted for 81.4% of HRI, and individuals with pathogenic variant (PV) for 18.6%. Malignant (n=8) and pre-malignant (1 PanIN3) lesions were found in nine individuals. Five of these 8 cases occurred in PV carriers, four in FPC cases (two tested negative at germline testing, and two others were not tested). Three of the 8 PC were Stage I. Five of the 8 PC were resectable, 3 Stage I, all advanced cases being prevalent. The 1-, 2-, and 3-year cumulative hazard of PC was 1.7%, 2.5% and 3%, respectively. Median overall and disease-free survival of resected PC patients were 18 and 12 months (95%CI not computable). Considering HRI who underwent baseline imaging, six pancreatic neuroendocrine neoplasms (one resected) and one low-yield surgery (low-grade mixed-IPMN) were also reported.PC surveillance in a fully public healthcare system is feasible, safe, and leads to early PC or pre-malignant lesions diagnoses, mostly at baseline but also over time." @default.
• W4387296265 created "2023-10-04" @default.
• W4387296265 creator A5004976398 @default.
• W4387296265 creator A5009789603 @default.
• W4387296265 creator A5011078535 @default.
• W4387296265 creator A5016906180 @default.
• W4387296265 creator A5018440372 @default.
• W4387296265 creator A5019756541 @default.
• W4387296265 creator A5022836234 @default.
• W4387296265 creator A5023897998 @default.
• W4387296265 creator A5025062457 @default.
• W4387296265 creator A5026161976 @default.
• W4387296265 creator A5028932175 @default.
• W4387296265 creator A5034751180 @default.
• W4387296265 creator A5037832760 @default.
• W4387296265 creator A5042336096 @default.
• W4387296265 creator A5042576726 @default.
• W4387296265 creator A5044729691 @default.
• W4387296265 creator A5047343226 @default.
• W4387296265 creator A5047796715 @default.
• W4387296265 creator A5048017669 @default.
• W4387296265 creator A5048095559 @default.
• W4387296265 creator A5048645120 @default.
• W4387296265 creator A5049763605 @default.
• W4387296265 creator A5052519619 @default.
• W4387296265 creator A5055546307 @default.
• W4387296265 creator A5055595209 @default.
• W4387296265 creator A5056335013 @default.
• W4387296265 creator A5057380925 @default.
• W4387296265 creator A5058221406 @default.
• W4387296265 creator A5060018577 @default.
• W4387296265 creator A5065743678 @default.
• W4387296265 creator A5067658527 @default.
• W4387296265 creator A5069023355 @default.
• W4387296265 creator A5071657406 @default.
• W4387296265 creator A5071900951 @default.
• W4387296265 creator A5072356061 @default.
• W4387296265 creator A5074272372 @default.
• W4387296265 creator A5074617047 @default.
• W4387296265 creator A5074748035 @default.
• W4387296265 creator A5074762554 @default.
• W4387296265 creator A5075436791 @default.
• W4387296265 creator A5077291679 @default.
• W4387296265 creator A5080824378 @default.
• W4387296265 creator A5084775918 @default.
• W4387296265 creator A5085112023 @default.
• W4387296265 creator A5085191511 @default.
• W4387296265 creator A5089237045 @default.
• W4387296265 creator A5089615706 @default.
• W4387296265 creator A5089630939 @default.
• W4387296265 creator A5090445455 @default.
• W4387296265 date "2023-10-03" @default.
• W4387296265 modified "2023-10-04" @default.
• W4387296265 title "Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer" @default.
• W4387296265 doi "https://doi.org/10.14309/ajg.0000000000002546" @default.
• W4387296265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37787643" @default.
• W4387296265 hasPublicationYear "2023" @default.
• W4387296265 type Work @default.
• W4387296265 citedByCount "0" @default.
• W4387296265 crossrefType "journal-article" @default.
• W4387296265 hasAuthorship W4387296265A5004976398 @default.
• W4387296265 hasAuthorship W4387296265A5009789603 @default.
• W4387296265 hasAuthorship W4387296265A5011078535 @default.
• W4387296265 hasAuthorship W4387296265A5016906180 @default.
• W4387296265 hasAuthorship W4387296265A5018440372 @default.
• W4387296265 hasAuthorship W4387296265A5019756541 @default.
• W4387296265 hasAuthorship W4387296265A5022836234 @default.
• W4387296265 hasAuthorship W4387296265A5023897998 @default.
• W4387296265 hasAuthorship W4387296265A5025062457 @default.
• W4387296265 hasAuthorship W4387296265A5026161976 @default.
• W4387296265 hasAuthorship W4387296265A5028932175 @default.
• W4387296265 hasAuthorship W4387296265A5034751180 @default.
• W4387296265 hasAuthorship W4387296265A5037832760 @default.
• W4387296265 hasAuthorship W4387296265A5042336096 @default.
• W4387296265 hasAuthorship W4387296265A5042576726 @default.
• W4387296265 hasAuthorship W4387296265A5044729691 @default.
• W4387296265 hasAuthorship W4387296265A5047343226 @default.
• W4387296265 hasAuthorship W4387296265A5047796715 @default.
• W4387296265 hasAuthorship W4387296265A5048017669 @default.
• W4387296265 hasAuthorship W4387296265A5048095559 @default.
• W4387296265 hasAuthorship W4387296265A5048645120 @default.
• W4387296265 hasAuthorship W4387296265A5049763605 @default.
• W4387296265 hasAuthorship W4387296265A5052519619 @default.
• W4387296265 hasAuthorship W4387296265A5055546307 @default.
• W4387296265 hasAuthorship W4387296265A5055595209 @default.
• W4387296265 hasAuthorship W4387296265A5056335013 @default.
• W4387296265 hasAuthorship W4387296265A5057380925 @default.
• W4387296265 hasAuthorship W4387296265A5058221406 @default.
• W4387296265 hasAuthorship W4387296265A5060018577 @default.
• W4387296265 hasAuthorship W4387296265A5065743678 @default.
• W4387296265 hasAuthorship W4387296265A5067658527 @default.
• W4387296265 hasAuthorship W4387296265A5069023355 @default.
• W4387296265 hasAuthorship W4387296265A5071657406 @default.
• W4387296265 hasAuthorship W4387296265A5071900951 @default.
• W4387296265 hasAuthorship W4387296265A5072356061 @default.
• W4387296265 hasAuthorship W4387296265A5074272372 @default.
• W4387296265 hasAuthorship W4387296265A5074617047 @default.
• W4387296265 hasAuthorship W4387296265A5074748035 @default.
• W4387296265 hasAuthorship W4387296265A5074762554 @default.
• W4387296265 hasAuthorship W4387296265A5075436791 @default.

• next